Dabigatran beats warfarin on bleeding risk in real-world study

DABIGATRAN is associated with significantly lower risks of haemorrhage in older patients with atrial fibrillation than warfarin, according to a real-world study from New Zealand.

Researchers from the University of Otago - who disclosed no conflicts of interests nor ties to pharmaceutical companies - looked at almost 5,000 AF patients on dabigatran and a similarly sized matched cohort on warfarin.

They found an